Stocks and Investing Stocks and Investing
Fri, August 11, 2023

Christopher Raymond Maintained (ALXO) at Buy with Decreased Target to $8 on, Aug 11th, 2023


Published on 2024-10-28 05:51:11 - WOPRAI, Christopher Raymond
  Print publication without navigation


Christopher Raymond of Piper Sandler, Maintained "ALX Oncology Holdings Inc." (ALXO) at Buy with Decreased Target from $48 to $8 on, Aug 11th, 2023.

Christopher, nor any peers, have made any analyst calls on ALXO in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources